Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
CLEO Diagnostics Ltd ( (AU:COV) ) just unveiled an announcement.
Cleo Diagnostics Limited reported a 12.8% decrease in revenues to $339,590 for the year ending June 30, 2025, alongside a 6.4% increase in losses, totaling $3,999,134. The company did not declare any dividends for the period, and the net tangible assets per ordinary security decreased from 6.99 cents to 4.26 cents, indicating financial challenges and potential implications for stakeholders.
More about CLEO Diagnostics Ltd
Cleo Diagnostics Limited operates in the healthcare industry, focusing on diagnostic services and products. The company is involved in developing and providing diagnostic solutions, although specific market focus details are not provided.
Average Trading Volume: 68,152
Technical Sentiment Signal: Hold
Find detailed analytics on COV stock on TipRanks’ Stock Analysis page.